Stereoselective binding of prasugrel active metabolite to the P2Y12 receptor: insights from a molecular modeling approach

This study employs molecular modeling techniques to demonstrate that the RS stereoisomer of prasugrel's active metabolite exhibits preferential, stereoselective binding to the closed P2Y12 receptor conformation, driven by a more energetically favorable disulfide bridge formation with cysteine 175 and distinct interactions with extracellular loops compared to other stereoisomers.

The Gist

The Big Picture: A Lock, a Key, and a Master Mechanic

Imagine your body has a specific "lock" on your blood cells called the P2Y12 receptor. When this lock is turned, it tells your blood cells to clump together and form a clot. In patients who have had a heart attack, we want to keep this lock stuck in the "off" position so clots don't form.

Prasugrel is a popular medicine (a "prodrug") designed to jam this lock. However, the liver has to process it first, turning it into its active form, called PAM (Prasugrel Active Metabolite).

Here is the tricky part: When the liver makes PAM, it accidentally creates four slightly different versions of the same key. These are called stereoisomers. Think of them like four keys that look almost identical, but one is slightly twisted to the left, one to the right, and so on.

Scientists already knew that one version (the RS key) was a "super-key" that jammed the lock much better than the others. But they didn't know why. This paper used powerful computer simulations to figure out the secret.

---

The Investigation: How the Computer Sleuths Worked

The researchers used three different "tools" to solve the mystery, like a detective using a magnifying glass, a map, and a chemistry set.

1. The Shape-Shifting Lock (Molecular Dynamics)

First, they realized the lock (the receptor) isn't rigid; it's like a flexible rubber band. It can be Open (relaxed) or Closed (tight).

• The Finding: The PAM keys prefer to enter the Closed version of the lock. It's like trying to fit a key into a door that is already slightly ajar; it's much easier to get a grip when the door is closed tight.

2. The Crowd of Keys (Ensemble Docking)

Next, they simulated throwing all four versions of the key at the lock millions of times to see where they landed.

• The Finding: Surprisingly, all four keys fit into the lock with about the same "snugness" (affinity). Just because a key fits well doesn't mean it's the best one. The difference wasn't in how they fit, but where they stopped inside the lock.

3. The Deep Dive vs. The Surface Dwellers

This is where the story gets interesting. The researchers looked closely at where the keys sat once they were inside.

• The RR Key (The Deep Diver): This key dives deep into the core of the lock, burying itself among the internal gears.
• The RS Key (The Surface Dweller): This key stays closer to the entrance (the surface) of the lock.
• Why it matters: The "super-key" (RS) stays near the entrance, which happens to be right next to a specific spot on the lock called Cysteine 175. The "deep diver" (RR) is too far away to touch this spot.

The "Velcro" Moment: The Chemical Bond

The magic of Prasugrel isn't just that it fits; it's that it glues itself to the lock. It does this by forming a chemical "bridge" (a disulfide bond) with a specific part of the lock (Cysteine 175).

Imagine the lock has a piece of Velcro on it. The key also has a piece of Velcro. To work, they have to touch.

• Because the RS key stays near the surface, its Velcro is right next to the lock's Velcro. They snap together easily.
• Because the RR key dives too deep, its Velcro is too far away to touch the lock's Velcro. It has to stretch, which is hard and takes a lot of energy.

The computer calculations (using a method called DFT) proved that snapping the RS key into place requires much less energy than trying to snap the RR key. It's like trying to zip a jacket: the RS key is already aligned with the zipper, while the RR key is twisted and fighting the fabric.

The "Traffic Jam" Analogy

The paper also explains why other drugs might interfere with Prasugrel.

• There is a drug called Cangrelor and a metabolite called PIM that also try to jam the lock.
• Because the RS key stays near the surface (the second extracellular loop), it shares the same "waiting room" as Cangrelor and PIM.
• If Cangrelor or PIM are there, they block the RS key from getting close enough to snap its Velcro. This explains why these drugs can compete with Prasugrel. The "deep diver" (RR) wouldn't be affected as much because it goes to a different room, but since it's a weaker key anyway, it doesn't matter.

The Conclusion: Why This Matters

The study solved the mystery:

1. The RS version is the winner because it stays close to the surface of the lock.
2. This position allows it to easily form a chemical glue (disulfide bond) with the lock's Cysteine 175.
3. The other versions (like RR) dive too deep, making it hard for them to glue themselves in place.

Why should you care?
Understanding exactly how the super-key works helps scientists design better, safer, and more effective heart medicines in the future. Instead of guessing which key works best, they can now build keys that are perfectly shaped to snap onto the lock instantly, ensuring patients get the best protection against heart attacks.

Technical Summary

1. Problem Statement

Prasugrel is a widely used prodrug for antiplatelet therapy in acute coronary syndrome (ACS). Its active metabolite, Prasugrel Active Metabolite (PAM), acts as an irreversible antagonist of the P2Y12 receptor by forming a covalent disulfide bridge with specific cysteine residues (Cys97 or Cys175).

Despite its clinical importance, the molecular mechanism of PAM binding remains poorly understood. Key challenges include:

• Stereoselectivity: PAM possesses two chiral centers, resulting in four stereoisomers (RS, SR, RR, SS). In vitro data shows significant differences in potency, with the RS stereoisomer being the most potent (IC50: 0.19 µM) compared to RR (3.1 µM), SS (28 µM), and SR (36 µM). The structural basis for this selectivity is unknown.
• Receptor Dynamics: The P2Y12 receptor exists in "open" (basal) and "closed" (active) conformations. It is unclear which conformation PAM prefers and how the specific stereoisomers interact with these states.
• Binding Site Ambiguity: While Cys97 and Cys175 are known binding sites, the precise orientation of the different stereoisomers and the energetics of the disulfide bond formation have not been elucidated.

2. Methodology

The authors employed a multi-scale computational approach combining Molecular Dynamics (MD), Ensemble Docking, and Quantum Chemistry (DFT) to rationalize the stereoselectivity.

• Molecular Dynamics (MD):

  • Simulated the P2Y12 receptor in both open (4NTJ) and closed (4PXZ) conformations.
  • Used a realistic lipid bilayer environment based on platelet plasma membrane lipidomics (high arachidonic acid content, 30% cholesterol) using CHARMM36 force fields.
  • Simulations included a 200 ns production phase.
  • Additional MD simulations were performed with RS and RR stereoisomers covalently bound to Cys97 and Cys175 to study binding pocket stability.

• Ensemble Docking:

  • Performed on 833 distinct protein conformations extracted from the last 50 ns of MD simulations to account for receptor flexibility.
  • Used QuickVina-2 to dock all four PAM stereoisomers into both open and closed receptor states.
  • Analyzed binding affinities and S-S distances (between PAM sulfur and receptor cysteines).

• Quantum Chemistry (DFT):

  • Utilized Density Functional Theory (DFT) with the ONIOM approach (B3LYP/6-31g(d) for the low layer; MPW1N/6-31g(d) for the high layer) to model the chemical reaction of disulfide bond exchange.
  • Focused on the reaction between Cys175 and the RS/RR stereoisomers.
  • Calculated activation energy barriers and Gibbs free energy changes ($\Delta_r G$) for the formation of the covalent bond.

3. Key Contributions & Results

A. Receptor Conformation Preference

• Closed Conformation Preference: Ensemble docking revealed that the closed conformation of P2Y12 is significantly more favorable for PAM binding than the open conformation, regardless of the stereoisomer. This aligns with the closed state being the active form of the receptor.
• Affinity Similarity: Non-covalent binding affinities were comparable across all four stereoisomers in the closed state, suggesting that initial physical binding does not solely explain the observed stereoselectivity.

B. Stereoselective Binding Geometry

• S-S Distance: In the closed conformation, the RS stereoisomer exhibited the shortest distance between its sulfur atom and Cys175 (nearly 50% of poses < 5 Å). The RR stereoisomer was the second closest, followed by SS and SR. This spatial proximity correlates directly with the in vitro potency ranking.
• Binding Depth:
  • RS Stereisomer: Binds closer to the receptor surface, interacting primarily with the second and third extracellular loops.
  • RR Stereisomer: Binds deeper within the transmembrane helices (interacting with Helices III, IV, V, VI).
• Competition Mechanism: The superficial binding of the RS stereoisomer places it in the same pocket as the reversible antagonist cangrelor and the intermediate metabolite PIM (Prasugrel Intermediate Metabolite). This explains the observed competitive inhibition between PAM and these agents.

C. Energetics of Covalent Bond Formation

• Activation Barriers: DFT calculations quantified the energy required to break the native Cys97-Cys175 disulfide bridge and form a new bond with PAM.
  • RS Stereisomer: Activation energy barrier = 15.5 kcal mol⁻¹.
  • RR Stereisomer: Activation energy barrier = 25.3 kcal mol⁻¹.
• Thermodynamics: Both reactions are endergonic ($\Delta_r G$ > 0), but the lower barrier for the RS stereoisomer makes the reaction kinetically much more favorable. The labile nature of the native Cys97-Cys175 bridge facilitates this exchange.

4. Significance and Conclusion

This study provides the first molecular-level explanation for the stereoselectivity of prasugrel's active metabolite. The key findings are:

1. Dual Mechanism of Selectivity: The superior potency of the RS stereoisomer is not due to higher initial non-covalent affinity, but rather a combination of:
   • Physical Positioning: The RS isomer localizes closer to the surface and Cys175, facilitating the necessary S-S proximity.
   • Chemical Kinetics: The lower activation energy barrier for the RS isomer makes the formation of the irreversible disulfide bond significantly faster and more favorable than for the RR isomer.
2. Binding Site Specificity: The study confirms that PAM preferentially binds to the closed conformation of P2Y12 and covalently links to Cys175 (located in the second extracellular loop) rather than Cys97.
3. Clinical Implications: The findings explain why cangrelor and PIM compete with prasugrel (overlapping binding pockets in the extracellular loops) and suggest that future antiplatelet agents could be optimized by targeting the specific geometry required for rapid disulfide exchange with Cys175.

In summary, the paper demonstrates that the conformation of the RS stereoisomer and the lower energy barrier for disulfide bridge formation are the critical factors driving the stereoselective efficacy of prasugrel.